Jushi Holdings Inc (JUSHF)
0.70
-0.02
(-2.79%)
USD |
OTCM |
May 17, 15:59
Jushi Holdings Gross Profit Margin (Quarterly): 49.39% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 49.39% |
December 31, 2023 | 40.16% |
September 30, 2023 | 43.61% |
June 30, 2023 | 46.00% |
March 31, 2023 | 42.85% |
December 31, 2022 | 28.58% |
September 30, 2022 | 38.10% |
June 30, 2022 | 36.65% |
March 31, 2022 | 30.88% |
December 31, 2021 | 29.91% |
Date | Value |
---|---|
September 30, 2021 | 43.21% |
June 30, 2021 | 47.68% |
March 31, 2021 | 48.21% |
December 31, 2020 | 44.78% |
September 30, 2020 | 49.17% |
June 30, 2020 | 50.04% |
March 31, 2020 | 48.17% |
December 31, 2019 | 44.42% |
September 30, 2019 | 43.15% |
June 30, 2019 | 94.51% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
28.58%
Minimum
Dec 2022
94.51%
Maximum
Jun 2019
44.97%
Average
44.02%
Median
Gross Profit Margin (Quarterly) Benchmarks
Anika Therapeutics Inc | 60.78% |
Spero Therapeutics Inc | -- |
scPharmaceuticals Inc | 70.75% |
electroCore Inc | 83.69% |
NovaBay Pharmaceuticals Inc | 68.19% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -890.6% |
Return on Assets | -14.60% |
Return on Invested Capital | -32.93% |
Profit Margin (Quarterly) | -28.04% |
Operating Margin (Quarterly) | 6.29% |
Return on Net Operating Assets | -16.12% |